Joseph Horrigan
Technik-/Wissenschafts-/F&E-Leiter bei AMO Pharma Ltd.
Profil
Joseph Horrigan is currently an Associate Professor at The University of North Carolina at Charlotte and the Chief Medical Officer at AMO Pharma Ltd.
He previously worked as the VP-Clinical Development & Medical Affairs at Neuren Pharmaceuticals Ltd.
He earned a doctorate degree from the University of Rochester.
Aktive Positionen von Joseph Horrigan
| Unternehmen | Position | Beginn |
|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Joseph Horrigan
| Unternehmen | Position | Ende |
|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Joseph Horrigan
| Rochester Christian University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
